NM

Newtyn Management Portfolio holdings

AUM $660M
This Quarter Return
+9.19%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$423M
AUM Growth
+$423M
Cap. Flow
-$113M
Cap. Flow %
-26.67%
Top 10 Hldgs %
66.33%
Holding
83
New
3
Increased
17
Reduced
15
Closed
37

Top Buys

1
CNNE icon
Cannae Holdings
CNNE
$15.4M
2
GTX icon
Garrett Motion
GTX
$11.2M
3
CIO
City Office REIT
CIO
$8.44M
4
VTOL icon
Bristow Group
VTOL
$3.3M
5
MBI icon
MBIA
MBI
$2.79M

Top Sells

1
LW icon
Lamb Weston
LW
$15.8M
2
GTXAP
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
$15.1M
3
ADNT icon
Adient
ADNT
$14.1M
4
CUBI icon
Customers Bancorp
CUBI
$11.6M
5
AVTA
Avantax, Inc. Common Stock
AVTA
$10.5M

Sector Composition

1 Consumer Discretionary 28.61%
2 Healthcare 22.7%
3 Communication Services 13.35%
4 Real Estate 8.73%
5 Technology 7%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CYT
26
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$3.53M 0.83%
1,358,049
+405,102
+43% +$1.05M
PFSW
27
DELISTED
PFSweb, Inc.
PFSW
$3.37M 0.8%
746,406
+30,524
+4% +$138K
AMPY icon
28
Amplify Energy
AMPY
$159M
$2.66M 0.63%
393,214
-744,632
-65% -$5.04M
SNSE icon
29
Sensei Biotherapeutics
SNSE
$10.9M
$2.08M 0.49%
1,827,240
+286,320
+19% +$326K
WVE icon
30
Wave Life Sciences
WVE
$1.27B
$1.82M 0.43%
500,000
-14,028
-3% -$51.1K
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.69M 0.4%
+764,274
New +$1.69M
ADVM icon
32
Adverum Biotechnologies
ADVM
$68.2M
$1.59M 0.38%
1,000,000
-528,400
-35% -$840K
OLMA icon
33
Olema Pharmaceuticals
OLMA
$432M
$1.58M 0.37%
175,000
-200,000
-53% -$1.81M
BOLT icon
34
Bolt Biotherapeutics
BOLT
$9.29M
$1.28M 0.3%
1,000,000
-115,110
-10% -$147K
BDTX icon
35
Black Diamond Therapeutics
BDTX
$164M
$1.01M 0.24%
200,000
-106,609
-35% -$538K
ALGS icon
36
Aligos Therapeutics
ALGS
$75.1M
$874K 0.21%
900,000
-121,461
-12% -$118K
DBTX
37
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$770K 0.18%
200,000
-53,818
-21% -$207K
ORKA
38
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
$636K 0.15%
313,200
-206,565
-40% -$419K
AVIR icon
39
Atea Pharmaceuticals
AVIR
$275M
$334K 0.08%
+89,197
New +$334K
LW icon
40
Lamb Weston
LW
$7.88B
$248K 0.06%
2,157
-137,843
-98% -$15.8M
GBTG icon
41
American Express Global Business Travel
GBTG
$3.88B
$224K 0.05%
30,923
-1,027,275
-97% -$7.43M
BRLIR
42
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$63.8K 0.02%
457,409
– –
ARIZR
43
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$22.2K 0.01%
250,000
– –
LFLYW
44
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$19.2K ﹤0.01%
634,640
– –
VHAQ.RT
45
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$14.3K ﹤0.01%
250,000
– –
TCRR
46
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-1,015,920
Closed -$1.52M
GTXAP
47
DELISTED
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
– –
-1,693,092
Closed -$15.1M
LTCH
48
DELISTED
Latch, Inc. Common Stock
LTCH
– –
-1,200,000
Closed -$915K
AVTA
49
DELISTED
Avantax, Inc. Common Stock
AVTA
– –
-400,000
Closed -$10.5M
DNMR
50
DELISTED
Danimer Scientific, Inc.
DNMR
– –
-535,000
Closed -$1.85M
1
2
3 4